|   | 
      
      
        |   | 
      
      
        | 
           		
			 | 
        
          A BILL TO BE ENTITLED
         | 
      
      
        | 
           
			 | 
        
          AN ACT
         | 
      
      
        | 
           
			 | 
        relating to coverage for treatment of craniofacial abnormalities  | 
      
      
        | 
           
			 | 
        under certain health benefit plans. | 
      
      
        | 
           
			 | 
               BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | 
      
      
        | 
           
			 | 
               SECTION 1.  Subchapter D, Chapter 1367, Insurance Code, is  | 
      
      
        | 
           
			 | 
        amended by adding Section 1367.1535 to read as follows: | 
      
      
        | 
           
			 | 
               Sec. 1367.1535.  COVERAGE FOR TREATMENT OF CRANIOFACIAL  | 
      
      
        | 
           
			 | 
        ABNORMALITIES.  A health benefit plan described by Section 1367.153  | 
      
      
        | 
           
			 | 
        that provides coverage for reconstructive surgery for craniofacial  | 
      
      
        | 
           
			 | 
        abnormalities, as defined in accordance with that section, must  | 
      
      
        | 
           
			 | 
        provide coverage for the treatment of the primary conditions  | 
      
      
        | 
           
			 | 
        constituting craniofacial abnormalities and secondary conditions  | 
      
      
        | 
           
			 | 
        related to or arising from craniofacial abnormalities, including: | 
      
      
        | 
           
			 | 
                     (1)  oral and facial surgery, surgical management, and  | 
      
      
        | 
           
			 | 
        follow-up care; | 
      
      
        | 
           
			 | 
                     (2)  prosthetic treatments, including obturators and  | 
      
      
        | 
           
			 | 
        speech and feeding appliances; | 
      
      
        | 
           
			 | 
                     (3)  orthodontic treatment and management; | 
      
      
        | 
           
			 | 
                     (4)  preventive and restorative dentistry to ensure  | 
      
      
        | 
           
			 | 
        good health and adequate dental structures for orthodontic  | 
      
      
        | 
           
			 | 
        treatment or prosthetic management or therapy; | 
      
      
        | 
           
			 | 
                     (5)  speech-language pathology services, including  | 
      
      
        | 
           
			 | 
        evaluation and therapy; | 
      
      
        | 
           
			 | 
                     (6)  audiological assessments and amplification  | 
      
      
        | 
           
			 | 
        devices; | 
      
      
        | 
           
			 | 
                     (7)  otolaryngological treatment and management; | 
      
      
        | 
           
			 | 
                     (8)  psychological assessment and counseling; and | 
      
      
        | 
           
			 | 
                     (9)  genetic assessment counseling for the parents and  | 
      
      
        | 
           
			 | 
        child. | 
      
      
        | 
           
			 | 
               SECTION 2.  The change in law made by this Act applies only  | 
      
      
        | 
           
			 | 
        to a health benefit plan that is delivered, issued for delivery, or  | 
      
      
        | 
           
			 | 
        renewed on or after January 1, 2018.  A plan delivered, issued for  | 
      
      
        | 
           
			 | 
        delivery, or renewed before January 1, 2018, is governed by the law  | 
      
      
        | 
           
			 | 
        as it existed immediately before the effective date of this Act, and  | 
      
      
        | 
           
			 | 
        that law is continued in effect for that purpose. | 
      
      
        | 
           
			 | 
               SECTION 3.  This Act takes effect September 1, 2017. |